Literature DB >> 10613696

Identification and molecular characterization of GRA8, a novel, proline-rich, dense granule protein of Toxoplasma gondii.

K L Carey1, C G Donahue, G E Ward.   

Abstract

We have generated two monoclonal antibodies (MAbs 17.9 and A3.2) against Toxoplasma gondii, both of which localize to the dense granules of tachyzoites by immunoelectron microscopy. MAb 17.9 is directed against GRA6, a previously described 32 kDa dense granule protein. MAb A3.2 is directed against a novel 38 kDa dense granule protein, which we refer to as GRA8. GRA8 is released into the parasitophorous vacuole during or shortly after invasion and associates with the periphery of the vacuole. The cDNA sequence encoding GRA8 was determined by screening a T. gondii cDNA expression library with MAb A3.2. The deduced amino acid sequence of GRA8 consists of a polypeptide of 267 amino acids, with no significant homology to any other known protein. The sequence contains an amino terminal signal peptide, three degenerate proline-rich repeats in the central region and a potential transmembrane domain near the carboxy terminus. The most striking feature of GRA8 is its remarkably high proline content (24%).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10613696     DOI: 10.1016/s0166-6851(99)00160-7

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  43 in total

1.  Detection and characterization of excretory/secretory proteins from Toxoplasma gondii by monoclonal antibodies.

Authors:  E S Son; H W Nam
Journal:  Korean J Parasitol       Date:  2001-03       Impact factor: 1.341

Review 2.  Lytic cycle of Toxoplasma gondii.

Authors:  M W Black; J C Boothroyd
Journal:  Microbiol Mol Biol Rev       Date:  2000-09       Impact factor: 11.056

3.  Multiple functionally redundant signals mediate targeting to the apicoplast in the apicomplexan parasite Toxoplasma gondii.

Authors:  Omar S Harb; Bithi Chatterjee; Martin J Fraunholz; Michael J Crawford; Manami Nishi; David S Roos
Journal:  Eukaryot Cell       Date:  2004-06

4.  The Toxoplasma gondii rhoptry protein ROP4 is secreted into the parasitophorous vacuole and becomes phosphorylated in infected cells.

Authors:  Kimberly L Carey; Artemio M Jongco; Kami Kim; Gary E Ward
Journal:  Eukaryot Cell       Date:  2004-10

5.  Molecular cloning and characterization of peroxiredoxin from Toxoplasma gondii.

Authors:  E S Son; K J Song; J C Shin; H W Nam
Journal:  Korean J Parasitol       Date:  2001-06       Impact factor: 1.341

6.  A serine-arginine-rich (SR) splicing factor modulates alternative splicing of over a thousand genes in Toxoplasma gondii.

Authors:  Lee M Yeoh; Christopher D Goodman; Nathan E Hall; Giel G van Dooren; Geoffrey I McFadden; Stuart A Ralph
Journal:  Nucleic Acids Res       Date:  2015-04-13       Impact factor: 16.971

7.  Interactions between secreted GRA proteins and host cell proteins across the paratitophorous vacuolar membrane in the parasitism of Toxoplasma gondii.

Authors:  Hye-Jin Ahn; Sehra Kim; Hee-Eun Kim; Ho-Woo Nam
Journal:  Korean J Parasitol       Date:  2006-12       Impact factor: 1.341

8.  The Toxoplasma gondii dense granule protein GRA7 is phosphorylated upon invasion and forms an unexpected association with the rhoptry proteins ROP2 and ROP4.

Authors:  Joe Dan Dunn; Sandeep Ravindran; Seon-Kyeong Kim; John C Boothroyd
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

9.  Intervacuolar transport and unique topology of GRA14, a novel dense granule protein in Toxoplasma gondii.

Authors:  Michael E Rome; Josh R Beck; Jay M Turetzky; Paul Webster; Peter J Bradley
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

10.  Dynamic development of parasitophorous vacuole of Eimeria tenella transfected with the yellow fluorescent protein gene fused to different signal sequences from apicomplexan parasites.

Authors:  Tuanyuan Shi; Wenchao Yan; Huaibin Ren; Xianyong Liu; Xun Suo
Journal:  Parasitol Res       Date:  2008-09-25       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.